BackVor Biopharma Overview
Vor Biopharma Inc

Vor Biopharma Target Price

Analysts' average 12-month price target for Vor Biopharma is $25.

Get informed when a big investor buys or sells

+ Follow

Share Price

$22.34

Average Target Price

$24.509.7% upside

2 analysts in the last 4 months

High: $31 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-14WedbushMartin Fan$1819.4% downsideOpen
2026-04-15H.C. Wainwright$3138.8% upsideOpen
2025-12-23Robert W. Baird$46105.9% upsideOpen
2025-10-29H.C. Wainwright$55146.2% upsideOpen
2025-10-14Robert W. Baird$64186.5% upsideOpen
2025-09-24Stifel NicolausStephen Willey$55146.2% upsideOpen
2025-06-30H.C. Wainwright$386.6% downsideOpen
2022-04-27Goldman Sachs$673.1% downsideOpen

Vor Biopharma (VOR) FAQ

The latest target price for VOR is $25. Investors often review this figure alongside Vor Biopharma's historical trend and sector peers before judging valuation or financial health.

Vor Biopharma trades near $22.34 while the consensus target sits at $25 (9.7% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting VOR's target price ($25), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Vor Biopharma's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.